Cargando…
Fluoroquinolone resistance during 2000–2005 : An observational study
BACKGROUND: Moxifloxacin is a respiratory fluoroquinolone with a community acquired pneumonia indication. Unlike other fluoroquinolones used in our healthcare system, moxifloxacin's urinary excretion is low and thus we hypothesized that increased use of moxifloxacin is associated with an increa...
Autores principales: | Ryan, Richard J, Lindsell, Chris, Sheehan, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424048/ https://www.ncbi.nlm.nih.gov/pubmed/18501015 http://dx.doi.org/10.1186/1471-2334-8-71 |
Ejemplares similares
-
Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
por: Jabeen, Kauser, et al.
Publicado: (2011) -
Fluoroquinolone Resistance in Salmonella enterica Serotype Choleraesuis, Taiwan, 2000–2003
por: Chiu, Cheng-Hsun, et al.
Publicado: (2004) -
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020
por: Chatterjee, Samrat, et al.
Publicado: (2022) -
Fluoroquinolone resistance in Neisseria gonorrhoeae.
por: Knapp, J S, et al.
Publicado: (1997) -
Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000–2013
por: Grad, Yonatan H., et al.
Publicado: (2016)